Sorry! This job has expired and is no longer available on Recruit.net

View related jobs: Associate Marketing Director, Lifecycle Management (Respiratory) jobs | AstraZeneca Pharmaceuticals LP jobs | Cambridge jobs

Associate Marketing Director, Lifecycle Management (Respiratory)

19 days ago: AstraZeneca Pharmaceuticals LP

Job Description

Position Summary:
At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life.
Benralizumab (FASENRA®) is the only humanized, afucosylated, immunoglobulin G1k (IgG1k) isotype monoclonal antibody that directly binds to the human interleukin‑5 receptor alpha (hIL-5Rα) on eosinophils and basophils. Benralizumab is uniquely engineered to recruit natural killer cells directly to its target, resulting in active apoptosis via antibody-dependent cellular cytotoxicity (ADCC).
The targeted mechanism of action of Benralizumab induces direct and near complete depletion of eosinophils in the airways, lung, sputum, blood, and bone marrow. Depletion of eosinophils is rapid and durable, with blood eosinophils completely depleted (0 cells/μL) 24 hours following subcutaneous dosing with benralizumab and which remain depleted during treatment with doses given every 8 weeks.
Fasenra is currently indicated as an add on treatment to standard of care for patients with eosinophilic Severe Uncontrolled Asthma with approval granted in US, EU, Japan and Canada at February 2018. Future indications are part of the clinical development plan and include COPD, Nasal Polyps (currently in Ph3) and other eosinophilic non-airways diseases such as EGPA, HES and EoE (currently being assessed)
Fasenra is the first launched respiratory biologic for AstraZeneca and represents one of the top company priorities within the respiratory TA and the overall portfolio.
Within the Respiratory Global Portfolio and Product Strategy (GPPS) team and reporting to the Head of Asthma or Lifecycle Management (LCM), you will contribute to the development of marketing plans to maximize the value of the brand. You will be responsible for working with Brand Leadership team to develop and measure aspects of the brand strategy with a specific focus on opportunity assessments, global commercial projects and activity planning.
You will work cross functionally with colleagues in the AZ and MedImmune biotech units as well as the local MC teams to shape the development of the promotional plans
The successful individual will demonstrate strong skills in the areas of planning, strategic thinking, decision making, communication, leadership, problem solving and collaboration.
Major Duties and Responsibilities:
As the global Associate Marketing Director, Lifecycle Management (Respiratory) you will represent GPPS and be accountable for:
+ Leading the development and implementation of the brand promotional activity plan
+ Coordinating the roll out of global initiatives / projects with focus on the G8-12 markets
+ Being an active member of the global commercial working group and GBT
+ Engaging with the local marketing teams to ensure a flawless and aligned execution of the promotional plan
+ Provide promotional input to the global strategy / BSP
+ Engaging with KEEs to gather input to inform the promotional strategy and activities plan including advocacy development

Requirements/Qualifications:
Education: Business degree is required with science expertise as preferred
Experience:
+ Significant experience in healthcare or biopharma industry, with a strong preference for experience in the respiratory therapeutic area and biologic drugs.
+ In-depth understanding of commercial strategy, methodologies and tools (product profiling and positioning, forecasting, pricing & reimbursement, market research techniques, competitive intelligence resources)
+ Comfort operating in a highly regulated environment and industry
+ Proven experience of engaging with and leveraging insights from external customers e.g. KEEs, prescribers, payors

Special Skills/Abilities:
+ Strong planning,
+ Demonstrated ability to lead without authority
+ Ability to gauge the feasibility, impact and risks of proposed programs
+ Strong leadership and influencing skills to ensure a strong commercial focus in global projects
+ Ability to manage complex projects
+ Demonstrated ability to bring ideas to action
+ Strong analytical, organizational and communication skills (written and verbal) required
+ Proven ability to collaborate across functional and geographic boundaries

Next Steps – Apply Today!
To be considered for this exciting opportunity, please complete the full application on our website at your earliest convenience – it is the only way that our Recruiter and Hiring Manager can know that you feel well qualified for this opportunity. If you know someone who would be a great fit, please share this posting with them.
AstraZeneca is an equal opportunity employer. AstraZeneca will consider all qualified applicants for employment without discrimination on grounds of disability, gender or gender orientation, pregnancy or maternity leave status, race or national or ethnic origin, age, religion or belief, gender identity or re-assignment, marital or civil partnership status, protected veteran status (if applicable) or any other characteristic protected by law.

Position Summary:At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life. Benralizumab (FASENRA®) is the only humanized, afucosylated, immunoglobulin G1k (IgG1k) isotype monoclonal antibody that directly binds to the human interleukin‑5 receptor alpha (hIL-5Rα) on eosinophils and basophils. Benralizumab is uniquely engineered to recruit natural killer...